I start, run, and invest in companies – particularly those which advance healthcare by leveraging technology of all kinds.
Specialties: Clinical trials, late phase drug development, drug safety, start-up organizations, drug development innovation. Increasingly interested in proteomics and monoclonal antibody based biotech start-ups – particularly those with candidates that need to get to Phase IB/IIA trials.
Starting, building, running companies; recruiting, building, running sales, operations and engineering teams; architecting, building, launching large-scale products and services.